phase 1_2_completion
saveInstitute of Hematology & Blood Diseases Hospital — cyclophosphamide (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone B-Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia (CLL), Relapsed Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Data sources
globaldata
Found something off?
drug timeline · 2
same company · ±60 days · 1
related news · 3
🐶 often sniffed alongside
top 8- tagDLBCL6 co-mentions · 3 sources
- tagOncology5 co-mentions · 4 sources
- tagCLL4 co-mentions · 1 sources
- companySandoz Inc2 co-mentions · 1 sources
- tagHematology2 co-mentions · 1 sources
- companyCity of Hope1 co-mentions · 1 sources
- companyNational Cancer Institute US1 co-mentions · 1 sources
- companyGeneral Hospital of the People's Liberation Army1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that